Roberto Profeta
7Patents
6h-index
11Co-inventors
56Inventor score
Filing activity: Oct 6, 2006 → May 15, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7655693B2 | Compounds | Human Necessities | 12 | Active |
| US8153623B2 | Compounds | Chemistry; Metallurgy | 9 | Active |
| US8153681B2 | Method of treating epilepsy by administering 5-(4{[(2-fluorophenyl)methyl]oxy}phenyl)prolinamide | Human Necessities | 9 | Active |
| US7803833B2 | Compounds | Chemistry; Metallurgy | 8 | Active |
| US8143306B2 | Methods of treating bipolar disorders | Human Necessities | 8 | Active |
| US10280153B2 | Process for the preparation of pure nilotinib and its salt | Chemistry; Metallurgy | 6 | Active |
| US8933132B2 | Tricyclic substituted benzenesulfonamide piperazine derivatives as CAV2.2 calcium channel blockers | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.